WHO ICTRP trial
ENSAYO FASE II ALEATORIZADO, ABIERTO, MULTICÉNTRICO Y PROSPECTIVO DE…
EUCTR2008-008922-55-ES · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-008922-55-ES |
|---|---|
| Public title | ENSAYO FASE II ALEATORIZADO, ABIERTO, MULTICÉNTRICO Y PROSPECTIVO DE DOXORRUBICINA vs TRABECTEDINA Y DOXORRUBICINA EN PRIMERA LÍNEA DE PACIENTES CON SARCOMA DE PARTES BLANDAS AVANZADOS NO OPERABLES Y/O METASTÁSICOS |
| Scientific title | ENSAYO FASE II ALEATORIZADO, ABIERTO, MULTICÉNTRICO Y PROSPECTIVO DE DOXORRUBICINA vs TRABECTEDINA Y DOXORRUBICINA EN PRIMERA LÍNEA DE PACIENTES CON SARCOMA DE PARTES BLANDAS AVANZADOS NO OPERABLES Y/O METASTÁSICOS |
| Primary sponsor | Grupo Español de Investigación en Sarcomas |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Portugal;Spain |
| Conditions | Sarcoma de partes blandas avanzados no operables y/o metastásicos MedDRA version: 9 Level: HLGT Classification code 10041299 Term: Soft tissue sarcomas |
| Interventions | Trade Name: YONDELIS 0,25 mg polvo para concentrado para solución para perfusión Product Name: Yondelis Product Code: 07417001 Pharmaceutical Form: INN or Proposed INN: TRABECTEDINA Other descriptive name: TRABECTEDINA Concentration unit… |
| Registration date | Mar 23, 2009 |
| Secondary IDs | GEIS20 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: